RespireRx Pharmaceuticals Inc. Business Operations Contracts & Agreements
9 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Development Agreements (2)
- Services Agreements (1)
- Settlement Agreements (5)
- Debt Settlement Agreement in the amount of $54,000 dated January 30, 2024 related to Former Officer Noted dated on or about April 10, 2018 (Filed With SEC on February 2, 2024)
- Debt Settlement Agreement in the amount of $40,500 dated January 30, 2024 related to Former Officer Noted dated on or about September 22, 2016 (Filed With SEC on February 2, 2024)
- Debt Settlement Agreement in the amount of $85,500 dated January 30, 2024 related to Former Officer Noted dated on or about February 2, 2016 (Filed With SEC on February 2, 2024)
- Master Intercompany Services Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd dated August 3, 2023 (Filed With SEC on August 9, 2023)
- First Amendment to Settlement Agreement and Release, dated as of December 16, 2019, between RespireRx Pharmaceuticals Inc. and Salamandra, LLC (Filed With SEC on October 14, 2020)
- Settlement Agreement and Release, dated August 21, 2019, between RespireRx Pharmaceuticals Inc. and Salamandra, LLC (Filed With SEC on October 14, 2020)
- Development and Supply Agreement, dated September 4, 2018 (Filed With SEC on October 14, 2020)
- Development and Supply Agreement, dated September 4, 2018, between the Company and Noramco, Inc (Filed With SEC on November 16, 2018)
- CONFIDENTIAL PORTIONS OMITTED PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 RESTATED AMENDMENT N°2 TO THE COLLABORATION RESEARCH (Filed With SEC on February 12, 2004)
